Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy

Alço, G.; Iğdem, S. I.; Ercan, T.; Dinçer, M.; Şentürk, R.; Atilla, S.; Zengin, F. Oral; Okkan, S.
December 2010
British Journal of Radiology;Dec2010, Vol. 83 Issue 996, p1072
Academic Journal
The aim of this study is to evaluate the coverage of axillary nodal volumes with high tangent fields (HTF) in breast radiotherapy and to determine the utility of customised blocking. The treatment plans of 30 consecutive patients with early breast cancer were evaluated. The prescription dose was 50 Gy to the whole breast. Axillary level I-II lymph node volumes were delineated and the cranial border of the tangential fields was set just below the humeral head to create HTF. Dose-volume histograms (DVH) were used to calculate the doses received by axillary nodal volumes. In a second planning set, HTF were modified with multileaf collimators (MLC-HTF) to obtain an adequate dose coverage of axillary nodes. The mean doses of the axillary nodes, the ipsilateral lung and heart were compared between the two plans (HTF vs MLC-HTF) using a paired sample t-test. The doses received by 95% of the breast volumes were not significantly different for the two plans. The doses received by 95% of the level I and II axillary volumes were 16.79 Gy and 11.59 Gy, respectively, for HTF, increasing to 47.2 Gy and 45.03 Gy, respectively, for MLC-HTF. Mean lung doses and per cent volume of the ipsilateral lung receiving 20 Gy (V20) were also increased from 6.47 Gy and 10.47%, respectively, for HTF, to 9.56 Gy and 16.77%, respectively, for MLC-HTF. Our results suggest that HTF do not adequately cover the level I and II axillary lymph node regions. Modification of HTF with MLC is necessary to obtain an adequate coverage of axillary levels without compromising healthy tissue in the majority of the patients.


Related Articles

  • Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement. Fontenot, J. D.; King, M. L.; Johnson, S. A.; Wood, C. G.; Price, M. J.; Lo, K. K. // British Journal of Radiology;Mar2012, Vol. 85 Issue 1011, p231 

    Objectives: Volumetric-modulated arc therapy (VMAT) is becoming an increasingly utilised modality for treating a variety of anatomical sites. However, the efficacy of single-arc VMAT to treat prostate cancer suspicious for extraprostatic extension was heretofore unknown. In this work, we report...

  • Perspectives on the adaptive response from studies on the response to low radiation doses (or to cisplatin) in mammalian cells. Skov, K.A. // Human & Experimental Toxicology;1999, Vol. 18 Issue 7, p447 

    Introduces a series of articles which deals with the adaptive responses on the response to low radiation doses.

  • Radiation exposure and adaptive processes. Mossman, K.L.; Ledesma, L.M. // Human & Experimental Toxicology;1999, Vol. 18 Issue 7, p436 

    Provides information on a study related to adaptive response and radiation exposure. Relation of the dose that induces the adaptive response to human and environmental exposures; Effects of inducing the adaptive response; Association of the adaptive response to the concept of hormesis.

  • Radioadaptive response: responses to the five questions. Ikushima, T. // Human & Experimental Toxicology;1999, Vol. 18 Issue 7, p433 

    Presents responses to several questions related to the adaptive response (AR) to ionizing radiation. Relevance of AR to human and environmental exposures; Analysis on whether the induction of AR can be manipulated for medical and other benefits; How does AR relate to the concept of hormesis.

  • The role of adaptive responses following exposure to ionizing radiation. Feinendegen, L.E. // Human & Experimental Toxicology;1999, Vol. 18 Issue 7, p426 

    Discusses how the dose that induces the adaptive response (AR) relate to human and environmental exposures. Definition of dose; Discussion on the absorption of the ionizing radiation; Meaning of dose rate.

  • No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study. Nordenskjöld, A. E.; Fohlin, H.; Albertsson, P.; Arnesson, L. G.; Chamalidou, C.; Einbeigi, Z.; Holmberg, E.; Nordenskjöld, B.; Karlsson, P. // Annals of Oncology;Jun2015, Vol. 26 Issue 6, p1149 

    Background: In published radiotherapy trials, the failure rate in the control arm among patients with one to three positive nodes is high compared with that seen with modern adjuvant treatments. Therefore, the generalizability of the results has been questioned. The aim of the present study was...

  • Biopsy battle favours SLNB.  // PharmacoEconomics & Outcomes News;1/23/2010, Issue 595, p10 

    The article discusses research on the cost and impact of sentinel lymph node biopsy on pain and quality of life of breast cancer patients compared with complete lymphadenectomy, that references a study by J.-M. Classe and colleagues presented in the 32nd Annual San Antonio Breast Cancer...

  • Sentinel Lymph Node Biopsy in Patients with Breast Cancer. Sadovsky, Richard // American Family Physician;01/15/2000, Vol. 61 Issue 2, p503 

    Deals with a study by S.S. Bass and associates which evaluated the effectiveness of lymphatic mapping and sentinel lymph node biopsy in the surgical treatment of patients with breast cancer. Methods of identifying the appropriate lymph node; Number of patients with breast cancer that...

  • Should we look to the sentinel node?  // Cortlandt Forum;11/25/99, Vol. 12 Issue 11, p123 

    Focuses on the use of sentinel lymph node (SLN) biopsy as an alternative to axillary lymph node dissection (ALND) for breast cancer. Postoperative complications of ALND; Methods to identify SLN; Key considerations before using SLN biopsy as replacement of ALND.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics